The IV Equipment Market is benefiting from the growing transition toward home-based healthcare. Patients are increasingly receiving selected intravenous therapies outside traditional hospital environments, creating demand for portable, convenient, and user-friendly IV equipment.

The global market was valued at USD 24.12 billion in 2024 and is forecast to grow from USD 24.88 billion in 2025 to USD 34.0 billion by 2035, at a CAGR of 3.17% during 2025–2035. North America accounted for more than 40.22% of global revenue in 2024, while Europe represented the second-largest regional market with a 24.88% share.

Home healthcare is changing the way intravenous treatment is delivered. Patients may prefer receiving therapy at home because of convenience, comfort, and reduced dependence on hospital visits. This trend is encouraging manufacturers to develop compact infusion systems and equipment that can be used effectively outside traditional clinical environments.

The home care settings segment is identified as the fastest-growing end-user category. Advances in IV technology are helping make home-based treatment more practical by improving portability, safety, monitoring, and ease of operation. These developments can support healthcare providers seeking to expand outpatient and home-based services.

The growing prevalence of chronic diseases is another factor supporting this transition. Patients with long-term conditions may require repeated or extended intravenous treatment, creating opportunities for healthcare systems to provide selected therapies in non-hospital settings.

Technological innovation is further strengthening the home healthcare opportunity. Smart infusion pumps, remote monitoring capabilities, and connected healthcare systems can provide healthcare professionals with improved visibility into treatment while supporting patient convenience.

At the same time, manufacturers must address regulatory and safety requirements when developing equipment for home use. Products need to be reliable, easy to operate, and designed to minimize potential risks associated with intravenous therapy.

The expansion of home healthcare represents an important long-term opportunity for IV equipment manufacturers. As healthcare delivery becomes increasingly patient-centered, demand for portable and connected intravenous technologies is expected to contribute significantly to market growth through 2035.